Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Real-time Estimate Cboe BZX 11:37:35 2024-04-25 am EDT 5-day change 1st Jan Change
311.1 USD -1.54% Intraday chart for Humana Inc. -4.31% -32.10%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Cuts Humana's Price Target to $326 From $334, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on Humana to $365 From $381 MT
Goldman Sachs Adjusts Price Target on Humana to $373 From $385 MT
RBC Cuts Price Target on Humana to $353 From $415, Keeps Outperform Rating MT
Cantor Fitzgerald Adjusts Price Target on Humana to $360 From $391 MT
Oppenheimer Adjusts Price Target on Humana to $370 From $415 MT
Stephens Adjusts Price Target on Humana to $350 From $395 MT
Bernstein Adjusts Price Target on Humana to $357 From $420 MT
Molina Healthcare beats profit estimates aided by higher premiums RE
Sector Update: Health Care Stocks Slipping Late Afternoon MT
Sector Update: Health Care Stocks Softer Wednesday Afternoon MT
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... Our Logo
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday MT
Transcript : Humana Inc., Q1 2024 Earnings Call, Apr 24, 2024
TD Cowen Lowers Humana Price Target to $396 from $427 MT
Nasdaq, S&P futures advance on tech boost, earnings glee RE
Humana's Q1 Adjusted Earnings Fall, Revenue Rises; 2024 Adjusted EPS Outlook Reaffirmed MT
Tranche Update on Humana Inc.'s Equity Buyback Plan announced on February 15, 2024. CI
Humana Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Humana beats first-quarter profit estimates on strength of Medicare business RE
Earnings Flash (HUM) HUMANA Posts Q1 EPS $7.23, vs. Street Est of $6.00 MT
Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024 CI
Cigna, Humana Merger Now Seems Plausible, Jefferies Says MT
Mizuho Adjusts Price Target on Humana to $385 From $400 MT
Jefferies Lowers Humana Price Target to $381 from $411 MT
Chart Humana Inc.
More charts
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
316 USD
Average target price
377.6 USD
Spread / Average Target
+19.51%
Consensus